| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. | J Pharmacol Exp Ther | 2001 | 3.59 |
| 2 | Cellular and molecular mechanisms of action of bisphosphonates. | Cancer | 2000 | 3.57 |
| 3 | Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. | Proc Natl Acad Sci U S A | 1999 | 2.66 |
| 4 | Molecular mechanisms of action of bisphosphonates. | Bone | 1999 | 1.33 |
| 5 | The pharmacology of bisphosphonates and new insights into their mechanisms of action. | J Bone Miner Res | 1999 | 1.30 |